Brad Cann

CFO at Zenith Epigenetics

Mr. Cann serves as Chief Financial Officer of Zenith, where he is responsible for overseeing corporate finance, financial reporting, corporate governance, and operations. With over 25 years of experience, Brad possesses a wealth of knowledge in a variety of financial and corporate roles. Brad has also served as the Chief Financial Officer of Resverlogix Corp. (TSX: RVX), a leading, late-stage clinical epigenetics company, since 2009.

Previously, Brad was Executive Vice President and Chief Financial Officer of Royal Host Real Estate Investment Trust. Prior to his positions with Royal Host, he was a business consultant and held senior management positions with several companies including Chief Financial Officer of Sulphur Corporation of Canada Ltd. Prior thereto, Brad held various positions with Kenway Mack Slusarchuk Stewart Chartered Accountants.

Timeline

  • CFO

    Current role